Union Pacific MAINTAINS Outperform and 4 Stock Analyses Turning Heads

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Medicis Pharmaceutical Corp. (NYSE:MRX): Following Valeant’s (NYSE:VRX) agreement to buy Medicis for $44 per share, Cantor does not believe that it will do much to assist Medicis. The firm keeps a Hold rating but raises its target to $44 per share from $36 on the stock.

Union Pacific Corporation (NYSE:UNP): After meeting with Union Pacific’s management, Wells Fargo thinks that the company continues to be exposed to favorable markets. The firm views the company’s current financial position as strong, and it reiterates an Outperform rating on the stock.

Equinix, Inc. (NASDAQ:EQIX) target has been raised by Stifel Nicolaus after meeting with the company’s CEO since the firm views the company’s fundamental trends as positive while there is a high probability that the company could become a REIT. The firm keeps a Buy rating on the stock.

LHC Group, Inc. (NASDAQ:LHCG) shares were removed because of an automatic time demotion.

Life Technologies Corporation (NASDAQ:LIFE): According to Oppenheimer, the Ion World conference, hosted by Life Technologies, should be a positive catalyst for the stock, as the research and clinical potential of Life’s Ion Proton program is to be described at the event. The firm believes that the program may add 6c to the company’s EPS during 2013, and 39c durink 2014. Oppenheimer keeps an Outperform rating on the stock.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business